Becton Dickinson (BDX) EPS (Basic) Growth (1y) (2010 - 2026)
Analysis
Becton Dickinson (BDX) EPS (Basic) Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 48.41 Bn | 47.55 Bn | 2.32 Bn | -31.18% |
| 2 | Medline | 27.78 Bn | 25.10 Bn | 2.22 Bn | - |
| 3 | West Pharmaceutical Services | 24.42 Bn | 23.98 Bn | 329.20 Mn | 18.95% |
| 4 | Baxter International | 12.49 Bn | 10.34 Bn | 1.03 Bn | 37.39% |
| 5 | Stevanato Group S.p.A | 5.70 Bn | 5.59 Bn | 100.91 Mn | -21.16% |
| 6 | Acme United | 235.29 Mn | 230.25 Mn | 26.69 Mn | 5.32% |
| 7 | Rockwell Medical | 31.39 Mn | 6.60 Mn | 3.24 Mn | 27.47% |
| 8 | Retractable Technologies | 21.15 Mn | -18.72 Mn | 190,852.00 | 2,011.45% |
| 9 | United Health Products | 8.85 Mn | 8.82 Mn | - | 25.95% |
| 10 | Cuprina Holdings (Cayman) | 7.88 Mn | 4.76 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -31.18% |
| Mar 31, 2026 | -203.37% |
| Dec 31, 2025 | 27.80% |
| Sep 30, 2025 | 24.16% |
| Jun 30, 2025 | 18.85% |
| Mar 31, 2025 | -42.20% |
| Dec 31, 2024 | 8.06% |
| Sep 30, 2024 | 265.92% |
| Jun 30, 2024 | 22.84% |
| Mar 31, 2024 | 20.39% |
| Dec 31, 2023 | -43.42% |
| Sep 30, 2023 | -59.43% |
| Jun 30, 2023 | 15.62% |
| Mar 31, 2023 | 1.96% |
| Dec 31, 2022 | -25.59% |
| Sep 30, 2022 | 11.15% |
| Jun 30, 2022 | -31.71% |
| Mar 31, 2022 | 58.79% |
| Dec 31, 2021 | -31.85% |
| Sep 30, 2021 | 122.26% |